Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243451 · ClinicalTrials.gov registry record
Early Detection of Mild Cognitive Impairment in Individual Patients
A clinical trial of Mild Cognitive Impairment and Mild Alzheimer's Disease, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Completed
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT00243451 is a study of Mild Cognitive Impairment and Mild Alzheimer's Disease that has completed, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 34 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00243451, a study of Mild Cognitive Impairment and Mild Alzheimer's Disease, has completed, sponsored by Louisiana State University Health Sciences Center Shreveport.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
Our central hypothesis is that the early metabolic lesions of MCI can be reliably detected in individual subjects by objective analysis of \[18\]F-fluorodeoxyglucose (FDG) positron-emission tomography (PET) brain images, earlier and more accurately than by subjective clinician rating.
Conditions Studied
Interventions
- OTHER PET scan & fMRI
Study Locations (1)
Louisiana
- Louisiana State University Health Sciences Center - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2003-09 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243451
The ClinicalTrials.gov registry entry for NCT00243451 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (97% lower). The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which PET scan & fMRI is the first listed.
NCT00243451 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT00243451 about?
NCT00243451 is a clinical study titled "Early Detection of Mild Cognitive Impairment in Individual Patients". Our central hypothesis is that the early metabolic lesions of MCI can be reliably detected in individual subjects by objective analysis of \[18\]F-fluorodeoxyglucose (FDG) positron-emission tomography (PET) brain images, earlier and more accurately than by subjective clinician rating.
What is the current status of trial NCT00243451?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2003-09. Estimated completion is 2011-07.
What conditions does trial NCT00243451 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Mild Alzheimer's Disease.
What interventions are being tested in trial NCT00243451?
The interventions under investigation include: PET scan & fMRI (OTHER).
Who is sponsoring clinical trial NCT00243451?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00243451 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
MCI Speech in Noise
RECRUITING
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.